Wednesday, November 11, 2026
ExploreSearch
Via News
Via News Knowledge File

Micron Technology Inc

organization80% conf.·synced Nov 11, 2026

Memory and storage solutions manufacturer

60
sourced metrics
907
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
725.11USD
Nov 10, 2026reference only
Market Cap
818934267722USD
Nov 10, 2026reference only
Price 52 Week Low
201.37USD
Nov 10, 2026reference only
Stock Return Ytd
129.9%
Nov 10, 2026reference only
Price 52 Week High
1213.56USD
Nov 10, 2026reference only
Shares Outstanding
1129393151.0shares
Jun 17, 2026reference only
Cash
24995000000.0USD
May 28, 2026reference only
Cost Of Revenue
6400000000.0USD
May 28, 2026reference only
Stockholders Equity
100724000000.0USD
May 28, 2026reference only
Revenue
41456000000.0USD
May 28, 2026reference only
Net Income
28243000000.0USD
May 28, 2026reference only
Gross Profit
35056000000.0USD
May 28, 2026reference only
Total Liabilities
33388000000.0USD
May 28, 2026reference only
Operating Income
33318000000.0USD
May 28, 2026reference only
Total Assets
134112000000.0USD
May 28, 2026reference only
Rd Expense
1316000000.0USD
May 28, 2026reference only
Eps
24.67USD_per_share
May 28, 2026reference only
Capex
5389000000.0USD
Nov 27, 2025reference only

Stated objectives

Achieve adjusted EPS of around $19.15 in Q3

source
target: 19.15 USD per share stated

Grow HBM market to $100 billion total addressable market

source
target: 100 billion USD by 2028-01-01 00:00:00stated

Begin production at Singapore HBM fab

source
by 2027-01-01 00:00:00stated

Begin DRAM production at retooled PSMC Taiwan fab

source
stated

Reach full production at Onondaga County, New York DRAM megafab complex

source
by 2030-01-01 00:00:00stated

Micron guided to Q1 FY2025 revenue between $12.2bn and $12.8bn

source
target: 12.2–12.8 billion USD stated

Micron guided to Q1 FY2025 adjusted EPS between $3.60 and $3.90

source
target: 3.60–3.90 USD EPS stated

$20 billion capital investment for fiscal 2026 including New York megafab and Idaho facility

source
target: 20 billion USD stated

Strategic focus on high-growth data center segments following exit from consumer products

source
stated

Complete first semiconductor fabrication facility outside Syracuse

source
by 2030-12-31 00:00:00stated

Relationship graph · 907 connections

Competes with
208
Supplies to
183
Covered by
164
Developed by
86
Invested in
50
Customer of
44
located in
31
Employs
30
has patent dispute with
Netlist

Via News coverage

Memory, Power and Photonics: Micron's Doubled Capex Shows Where the AI Buildup Is Landing
November 5, 2026
The AI Bottleneck Is Memory and Wiring, Not Just Compute: Micron's Spending Doubled While Nvidia, Bull and GlobalFoundries Chase Supply and Bandwidth
October 14, 2026
The AI chip crunch is a memory story first: Micron's spending has doubled, and Nvidia is co-developing its supply
October 12, 2026
Micron's Capex Doubled and Its Cash Tripled: The Checked Numbers Behind the AI Hardware Bull Case, and the Names Where Analysts Disagree With the Price
October 9, 2026
The AI memory squeeze: Micron's spending doubles, chip makers consolidate, and a reversible-computing startup rethinks the transistor
October 8, 2026
Micron's Capex Doubled in a Year While Cash Hit $25 Billion: The Checkable Core of the AI Memory Boom
October 1, 2026
AI Chip Deal-Making Keeps Accelerating While Semiconductor Stocks Lose a Quarter of Their Value
August 16, 2026
Nvidia Locks In HBM Supply and Washington Backs Silicon Photonics — Wall Street Sells the Chip Rally Anyway
August 15, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com